↓ Skip to main content

How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias

Overview of attention for article published in Pharmacoepidemiology & Drug Safety, January 2019
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
37 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias
Published in
Pharmacoepidemiology & Drug Safety, January 2019
DOI 10.1002/pds.4722
Pubmed ID
Authors

Robert W. Platt, Richard Platt, Jeffrey S. Brown, David A. Henry, Olaf H. Klungel, Samy Suissa

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 37 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 37 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 19%
Researcher 6 16%
Student > Ph. D. Student 4 11%
Other 3 8%
Professor > Associate Professor 2 5%
Other 3 8%
Unknown 12 32%
Readers by discipline Count As %
Medicine and Dentistry 8 22%
Pharmacology, Toxicology and Pharmaceutical Science 5 14%
Nursing and Health Professions 2 5%
Business, Management and Accounting 1 3%
Linguistics 1 3%
Other 4 11%
Unknown 16 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 July 2020.
All research outputs
#6,994,325
of 25,461,852 outputs
Outputs from Pharmacoepidemiology & Drug Safety
#616
of 2,176 outputs
Outputs of similar age
#141,401
of 464,380 outputs
Outputs of similar age from Pharmacoepidemiology & Drug Safety
#8
of 32 outputs
Altmetric has tracked 25,461,852 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 2,176 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.9. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 464,380 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.